Active Studies
Research Studies Currently Enrolling Participants
To find out more, click on the clinical trial that interests you. You will find a description of the trial and contact information for the research coordinator.
Showing 191-199 trials of 199 total
-
Genetics
Human Tumor Sequencing Project
This trial is currently enrolling
This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual’s response to certain treatments.
-
Cardiology and Vascular Diseases
MIRACLE EF
This trial is currently enrolling
This study is looking at whether the electrical treatment provided by a special type of pacemaker called a Cardiac Resynchronization Therapy (CRT) pacemaker may keep a patient’s heart failure from getting worse. When the lower heart chambers (i.e. ventricles) are electrically paced to beat ...
-
Cardiology and Vascular Diseases
Integrated Diagnostic Evaluation in Non-Therapy Devices For the Study of Heart Failure
This trial is currently enrolling
The purpose of this study is to characterize the feasibility and impact of a diagnostic tool that may help clinicians identify when patients are at higher risk of visiting the hospital for a heart failure event. The study will use a non-experimental device that is inserted just under the skin of ...
-
Hepatology
GS-US-334-0139 An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C infection
This trial is currently enrolling
This is a single arm, open-label study which will be opened at specific clinical sites at the request of an investigator for the treatment of individual subjects for whom there are no other treatment options. Subjects will be treated for 24 weeks with sofosbuvir (400mg QD) with RBV; pegylated ...
-
Genomics
Healthy Elderly Active Longevity (HEAL) Cohort
This trial is currently enrolling
With the completion of the human genome project, investigators can now explore new questions in human biology. Previously human genetics focused on highly penetrant, Mendelian traits; however, now rare and common variants can be discovered that affect “common” diseases that have ...
-
Cardiology and Vascular Diseases
MultiPoint Pacing IDE Study
This trial is currently enrolling
This IDE study is a prospective, randomized, double-blind, multi-center clinical study to evaluate the safety and efficacy of patient treatment with multi-point pacing compared to patient treatment with standard Biventricular pacing at 9 months. The study will be conducted at a maximum of 50 ...
-
Cardiology and Vascular Diseases
ABSORB RANDOMIZED CONTROLLED TRIAL: A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions (Protocol 10-392)
This trial is currently enrolling
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions.
-
Cardiology and Vascular Diseases
St. Jude Medical Cardiac Lead Assessment Study
This trial is currently enrolling
The objectives of the study are: 1. To determine the prevalence of externalized conductors at enrollment in Riata®, Riata® ST Silicone, QuickSite®/QuickFlex® and Durata® leads 2. To determine the prevalence of other visual lead anomalies (fracture, subclavian crush, kink, broken filars on a ...
-
Hepatology
A randomized, multicenter, double-blind, placebo-controlled, parallel-group, 24-week pilot study to assess the efficacy, safety and tolerability of LCQ908 in patients with non-alcoholic fatty liver disease Protocol No.: CLCQ908A2216
This trial is currently enrolling
The purpose of this study is to determine whether LCQ908 effectively lowers liver fat, as assessed by MRI and to assess its safety and tolerability profile in subjects with non-alcoholic fatty liver disease (NAFLD).